Olanzapine and Fluoxetine
Olanzapine and Fluoxetine is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand name including Olanzapine and Fluoxetine. Available dosage form: capsule.
Drug Details
- Generic Name
- Olanzapine and Fluoxetine
- Brand Names
- Olanzapine and Fluoxetine
- Application Number
- ANDA077528
- Sponsor
- Teva Pharmaceuticals USA, Inc.
- NDC Codes
- 10
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- OLANZAPINE, FLUOXETINE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Olanzapine and fluoxetine capsules are indicated for the treatment of: Acute depressive episodes in Bipolar I Disorder [see Clinical Studies (14.1) ]. Treatment resistant depression (Major Depressive Disorder in patient who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode) [see Clinical Studies (14.2) ]. Olanzapine and fluoxetine capsules combine olanzapine, an atypical antipsychotic and fluoxetine, a selective serotonin reuptake inhibitor, indicated for treatment of: Acute Depressive Episodes Associated with Bipolar I Disorder (1) Treatment Resistant Depression (1)